
Keywords: توریمیفن; Tamoxifen; Toremifene; Non-alcoholic fatty liver disease; Fatty liver; Alanine aminotransferase; ALT; alanine aminotransferase; BMI; body mass index; CT; computed tomography; DM; diabetes mellitus; HTN; hypertension; NAFLD; nonalcoholic fatty liver diseas